公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2007 | Reply | YEN-HSUAN NI ; MEI-HWEI CHANG ; PEI-JER CHEN | Gastroenterology | 0 | 0 | |
2006 | Reply [2] | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Hepatology | 0 | 0 | |
2006 | Reply [3] | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Hepatology | 0 | 0 | |
1995 | Reply To the Editor | Lin H.-H.; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN | The Journal of Pediatrics | 0 | 0 | |
2013 | Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia | Chen D.-S.; Locarnini S.; Wait S.; Bae S.-H.; PEI-JER CHEN ; Fung J.Y.Y.; Kim H.S.; Lu S.-N.; Sung J.; Tanaka J.; Wakita T.; Ward J.; Wallace J. | Journal of Hepatology | 22 | 23 | |
2018 | A research agenda for curing chronic hepatitis B virus infection | Alter H.; Block T.; Brown N.; Brownstein A.; Brosgart C.; Chang K.-M.; PEI-JER CHEN ; Chisari F.V.; Cohen C.; El-Serag H.; Feld J.; Gish R.; Glenn J.; Greten T.; Guo H.; Guo J.-T.; Hoshida Y.; Hu J.; Kowdley K.V.; Li W.; Liang J.; Locarnini S.; Lok A.S.; Mason W.; McMahon B.; Mehta A.; Perrillo R.; Revill P.; Rice C.M.; Rinaudo J.; Schinazi R.; Seeger C.; Shetty K.; Tavis J.; Zoulim F. | Hepatology | 63 | 61 | |
2018 | Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop | Block T.M.; Alter H.; Brown N.; Brownstein A.; Brosgart C.; Chang K.-M.; PEI-JER CHEN ; Cohen C.; El-Serag H.; Feld J.; Gish R.; Glenn J.; Greten T.F.; Guo J.-T.; Hoshida Y.; Kowdley K.V.; Li W.; Lok A.S.; McMahon B.; Mehta A.; Perrillo R.; Rice C.M.; Rinaudo J.; Schinazi R.F.; Shetty K. | Antiviral Research | 21 | 19 | |
1985 | Reverse transcription of 7S L RNA by an avian retrovirus | PEI-JER CHEN ; Cywinski, A.; Taylor, J. M. | Journal of Virology | 27 | 34 | |
2008 | A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial | CHIUN HSU ; Hsiung C.A.; Su I.-J.; Hwang W.-S.; Wang M.-C.; Lin S.-F.; Lin T.-H.; Hsiao H.-H.; Young J.-H.; Chang M.-C.; Liao Y.-M.; Li C.-C.; Wu H.-B.; HWEI-FANG TIEN ; Chao T.-Y.; Liu T.-W.; ANN-LII CHENG ; PEI-JER CHEN | Hepatology | 273 | 243 | |
2003 | Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; YUNG-MING JENG ; DING-SHINN CHEN | Hepatology | 118 | 94 | |
2001 | Ribavirin enhances interferon-γ levels in patients with chronic hepatitis C treated with interferon-α | Fang S.-H.; Lai M.-Y.; Hwang L.-H.; PEI-MING YANG ; PEI-JER CHEN ; BOR-LUEN CHIANG ; DING-SHINN CHEN | Journal of Biomedical Science | 22 | 18 | |
2011 | Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): Development and validation of a predictive score | Yang H.-I.; Yuen M.-F.; Chan H.L.Y.; Han K.-H.; PEI-JER CHEN ; Kim D.-Y.; Ahn S.-H.; Chen C.-J.; Wong V.W.S.; Seto W.-K. | The Lancet Oncology | 502 | 479 | |
2013 | Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers | TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Yang W.-T; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 45 | 44 | |
2005 | RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant | Wu H.-L.; Huang L.-R.; Huang C.-C.; Lai H.-L.; CHUN-JEN LIU ; Huang Y.-T.; Hsu Y.-W.; Lu C.-Y.; DING-SHINN CHEN ; PEI-JER CHEN | Gastroenterology | 96 | 93 | |
2021 | Robust induction of TRMs by combinatorial nanoshells confers cross-strain sterilizing immunity against lethal influenza viruses | Pin-Hung Lin; Chieh-Yu Liang; Bing-Yu Yao; Ching-Fu Pan; Li-Ling Wu; Yi-Hsuan Lin; Yu-Sung Hsu; Yu-Han Liu; PEI-JER CHEN ; HUI-WEN CHEN ; Che-Ming Jack Hu | Molecular Therapy - Methods and Clinical Development | 5 | 4 | |
2006 | Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers | CHUN-JEN LIU ; Chen B.-F.; PEI-JER CHEN ; Lai M.-Y.; Huang W.-L.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Infectious Diseases | 161 | 142 | |
2006 | Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: A case-control study | Lin C.-J.; Chen B.-F.; PEI-JER CHEN ; Lai M.-Y.; Huang W.-L.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Infectious Diseases | 117 | 110 | |
2011 | Role of microRNAs in hepatitis B virus replication and pathogenesis | Liu W.-H.; Shiou-Hwei Yeh ; PEI-JER CHEN | Biochimica et Biophysica Acta - Gene Regulatory Mechanisms | 82 | 78 | |
2000 | Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: Impact of smoking on risk | MING-WHEI YU ; Pai C.-I.; Yang S.-Y.; Hsiao T.-J.; Chang H.-C.; Lin S.-M.; Liaw Y.-F.; PEI-JER CHEN ; Chen C.-J. | Gut | 55 | 47 | |
2020 | The role of phylogenetic analysis in clarifying the infection source of a COVID-19 patient | JANN-TAY WANG ; Lin Y.-Y.; SUI-YUAN CHANG ; Shiou-Hwei Yeh ; Hu B.-H.; PEI-JER CHEN ; SHAN-CHWEN CHANG | Journal of Infection | 19 | 15 |